Cahill Financial Advisors Inc Bristol Myers Squibb CO Transaction History

Cahill Financial Advisors Inc

  • $707 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$53.63 - $62.52 $125,547 - $146,359
-2,341 Closed
0 $0
Q3 2021

Nov 16, 2021
BUY
$59.17 - $69.31 $138,516 - $162,254
2,341 New
2,341 $139,000
Q1 2020

May 15, 2020
SELL
$46.4 - $67.43 $145,000 - $210,718
-3,125 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$49.21 - $64.19 $153,781 - $200,593
3,125 New
3,125 $200,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cahill Financial Advisors Inc Portfolio

Follow Cahill Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cahill Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cahill Financial Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email